Skip to main content

Cassava Sciences Invited to Present in Four Upcoming Investor Conferences

Written by Customer Service on . Posted in Public Companies.

AUSTIN, Texas, Sept. 06, 2023 (GLOBE NEWSWIRE) — Cassava Sciences, Inc. (Nasdaq: SAVA), a biotechnology company committed to the treatment of Alzheimer’s disease dementia, today announced that it has been invited to present at the following investor conferences.

Event:Morgan Stanley – 21stAnnual Global Healthcare Conference
Format:Fireside chat with Remi Barbier, President & CEO
Date:Monday, September 11, 2023
Where:New York City
  
Event:H.C. Wainwright – 25thAnnual Global Investment Conference
Format:Corporate presentation by Eric Schoen, Chief Financial Officer
Date:Monday, September 11, 2023
Where:New York City
  
Event:JonesTrading – 2023 Healthcare Summit
Format:Fireside chat with Remi Barbier, President & CEO
Date:Tuesday, October 10th, 2023
Where:Miami
  
Event:Jefferies – Inaugural Biotech CNS/Neuro Summit
Format:Fireside chat with management
Date:Wednesday, October 11, 2023
Where:New York City
  

A webcast or subsequent archived replay of Cassava Sciences’ participation in these events may be available, depending on the conference and other factors. If a webcast or replay becomes available, it may be accessed via the Investors section of Cassava Sciences’ website at: www.CassavaSciences.com.

About Cassava Sciences, Inc.

Cassava Sciences is a clinical-stage biotechnology company based in Austin, Texas. Our mission is to detect and treat neurodegenerative diseases, such as Alzheimer’s disease. Our novel science is based on stabilizing—but not removing—a critical protein in the brain. Our product candidates have not been approved by any regulatory authority, and their safety, efficacy or other desirable attributes have not been established.

For more information, please visit: https://www.CassavaSciences.com

For More Information Contact:
Eric Schoen, Chief Financial Officer
(512) 501-2450
ESchoen@CassavaSciences.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.